scispace - formally typeset
M

Michael G. Ziegler

Researcher at University of California, San Diego

Publications -  455
Citations -  23786

Michael G. Ziegler is an academic researcher from University of California, San Diego. The author has contributed to research in topics: Blood pressure & Catecholamine. The author has an hindex of 78, co-authored 455 publications receiving 22509 citations. Previous affiliations of Michael G. Ziegler include San Diego State University & University of Massachusetts Medical School.

Papers
More filters
Journal ArticleDOI

Aerobic Fitness Affects Cardiovascular and Catecholamine Responses to Stressors

TL;DR: Blood pressure, heart rate, norepinephrine, epinephrine, and psychological responses to a film of industrial accidents, the Stroop word color task, the cold pressor test, and running to exhaustion on a treadmill in a test of the hypothesis that aerobic fitness is associated with decreased responsiveness to stressors other than exercise.
Journal ArticleDOI

Lymphocyte Subset Redistribution in Response to Acute Experimental Stress: Effects of Gender, Ethnicity, Hypertension, and the Sympathetic Nervous System

TL;DR: The findings suggest that traditional epidemiologic characteristics such as gender, ethnicity, and mild hypertension have limited influence on lymphocytosis and that interindividual differences in sympathetic nervous system characteristics play a more prominent underlying role in acute cellular immune system activation.
Journal ArticleDOI

Sleep apnea, norepinephrine-release rate, and daytime hypertension.

TL;DR: It is suggested that apneics are susceptible to transient increases in sympathetic nervous activity and that hypertensive apneic maintain increased sympathetic nervous release of NE in the daytime.
Journal ArticleDOI

A Randomized Clinical Trial of Behavioral Activation (BA) Therapy for Improving Psychological and Physical Health in Dementia Caregivers: Results of the Pleasant Events Program (PEP)

TL;DR: The PEP program decreased depression and improved a measure of physiological health in older dementia caregivers and future research should examine the efficacy of PEP for improving other CVD biomarkers and seek to sustain the intervention's effects.